Biotech & Life Sciences

The Biotech & Life Sciences Investment Committee represents expertise in drug development, clinical therapy, and medical device technologies and the wider biotechnology space.

Mike Bickerdike

Chairman | Consultant, BioTarget Consulting

View bio

Imche Fourie

Chief Executive Officer, Chiasma

View bio

Kaushala Ratnayake

View bio

Andy Shenk

CEO, Auckland UniServices

View bio

Will Charles

General Manager - Technology Development, Auckland UniServices

View bio

Dick Bellamy

Independent Research Professional

View bio

Margaret Brimble

Chair of Organic and Director of Medicinal Chemistry, University of Auckland

View bio

Evelyn Body

Corporate Counsel & IP Advisor

View bio

Kjesten Wiig

National Manager Commercialisation, Ministry of Business, Innovation and Employment

View bio

Julia Chambers

Business Innovation Advisor, Callaghan Innovation

View bio

Joshua Funder

View bio

Ian Boddy

Principal Investigator, IKBConsulting

View bio

Ken Taylor

CEO, Living Cell Technologies Ltd.

View bio

Hon Pete Hodgson

Hon Pete Hodgson

View bio

Colin Dawson

Independent

View bio

Andrew Wilks

Executive Chairman, SYNthesis med chem

View bio

Duncan Mackintosh

Investment Manager, Brandon Capital Partners

View bio

Phil Kearny

Director, Licensing & External Research, MSD Australia

View bio

Jim Mervis

Chairman, CoDa Therapeutics. CEO, Engender Technologies

View bio